Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis
NCT01525953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2012-02-03
Summary
The aim of this study is to identify prognostic factors for outcome in patients being complete clinical responders with chemoradiation or radiation for esophageal cancer
Conditions
- Esophageal Cancer
Interventions
- DRUG
-
Chemotherapy according to standard
- RADIATION
-
Radiotherapy
Radiotherapy according to local standard
Sponsors & Collaborators
-
Centre Oscar Lambret
lead OTHER
Principal Investigators
-
Antoine ADENIS, MD, PhD · Centre Oscar Lambret
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2012-01-31
- Completion
- 2012-01-31
Countries
- France
Study Locations
More Related Trials
-
Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma
NCT03790553 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer
NCT03301454 ·Status: TERMINATED ·Phase: PHASE2
-
Chemoradiotherapy for Advanced Esophageal Cancer
NCT02297217 ·Status: RECRUITING ·Phase: PHASE2
-
RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus
NCT00559351 ·Status: TERMINATED ·Phase: PHASE3
-
Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.
NCT01248299 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer
NCT02959385 ·Status: UNKNOWN ·Phase: PHASE2
-
Impact of Dose to Cardiac Substructures on Survival in Patients With Esophageal Cancer Treated With Radiotherapy or Chemoradiotherapy (SATIATION)
NCT05996276 ·Status: UNKNOWN
-
Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer
NCT07015489 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer
NCT05183958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002884 ·Status: UNKNOWN ·Phase: PHASE3
-
Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy
NCT04019548 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer
NCT01670409 ·Status: COMPLETED ·Phase: PHASE2
-
Chemoradiotherapy in Elderly Patients With Oesophagus Cancer
NCT02735057 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
NCT05594914 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC
NCT05394415 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery
NCT00416858 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
NCT04046575 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Genetic and Environmental Risk Factors Related to Esophageal Cancer
NCT01035398 ·Status: ACTIVE_NOT_RECRUITING
-
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
NCT00509561 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer
NCT01787006 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
NCT04207918 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer
NCT01249352 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China
NCT05194371 ·Status: COMPLETED
-
Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
NCT00193882 ·Status: COMPLETED ·Phase: PHASE3
-
Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma
NCT00230451 ·Status: COMPLETED ·Phase: PHASE2